No abstract available
MeSH terms
-
Adenocarcinoma / drug therapy*
-
Aged
-
Blepharoptosis / chemically induced*
-
Drug Therapy, Combination / adverse effects
-
Humans
-
Immune Checkpoint Inhibitors / adverse effects*
-
Immune Checkpoint Inhibitors / therapeutic use
-
Ipilimumab / adverse effects*
-
Ipilimumab / therapeutic use
-
Male
-
Nivolumab / adverse effects*
-
Nivolumab / therapeutic use
-
Prostatic Neoplasms / drug therapy*
Substances
-
Immune Checkpoint Inhibitors
-
Ipilimumab
-
Nivolumab